
Journal of Organometallic Chemistry p. 63 - 82 (1993)
Update date:2022-08-03
Topics:
Walter, Olaf
Klein, Thomas
Huttner, Gottfried
Zsolnai, Laszlo
The tripod ligand H3CC(CH2PPh2)3, 1, reacts with lithium metal to produce H3CC(CH2PPhLi)3, 2, in good yields.Compound 2 crystallizes in the form of 2*4THF*MeN(CH2CH2NMe2)2.The crystal structure of this adduct shows bridging as well as terminal phosphorous-coordination of lithium.Compound 2 reacts with electrophiles RX to give H3CC(CH2P(Ph)(R))3, 3 (R = H, Me, Et, iPr, CH2Ph, 3a-e).The transformation 1 <*> 2 <*> 3 can be performed in a one-pot reaction.While the chiral compounds 3 may be characterized as such, their reaction with (CH3CN)3Mo(CO)3 yields theeasy-to-characterize coordination compounds H3CC(CH3P(Ph)(R))3Mo(CO)3, 5.NMR analysis of 3 and 5 shows that from the two diastereomeric forms of 3 (the enantiomeric pair SSR/RRS and the pair SSS/RRR) only the SSR/RRS-diastereomer is formed with R = CH2Ph (3e, 5e).In the other cases (R = H, Me, Et, iPr) a statistical 3:1 mixture of the two diastereomers is formed.These findings are further corroborated by X-ray analyses of H3CC(CH2P(Ph)(Et))3Mo(CO)3, 5c, and H3CC(CH2P(Ph)(CH2Ph))3Mo(CO)3, 5e.The remarkable facts reported in this paper are the ease with which the chiral tripod ligands H3CC(CH2P(Ph)(R))3, 3, are prepared, and the evidence that their formation may well involve diastereoselective control.
View Morewebsite:http://www.amadischem.com
Contact:86-571-89925085
Address:Watts Cosine.No.166.Xiangmao Road.
Hebei Kangtai Pharmaceutical Co.,Ltd
Contact:+86-0317-3512963
Address:Wugang Road,Mengcun of Cangzhou City,Hebei Province ,China
Contact:+852-8198 2399
Address:9E, Leapont Industrial Building, 18-28 Wo Liu Hang Road, Shatin, New Territories, Hong Kong
Shijiazhuang Sdyano Fine Chemical Co., Ltd
Contact:+86-311-89830448
Address:NO.48 Ta Nan Road,Yuhua District,Shijiazhuang,Hebei,China
Contact:+86-21-61318535
Address:Building 29,No.2139 Xizha Road, Fengxian District, Shanghai
Doi:10.1016/S0040-4039(01)01825-1
(2001)Doi:10.1039/c3ra46270f
(2014)Doi:10.1080/00397910903340637
(2010)Doi:10.1016/0223-5234(93)90114-T
(1993)Doi:10.1055/s-1993-26037
(1993)Doi:10.7164/antibiotics.46.1919
(1993)